Elotuzumab for the treatment of extramedullary myeloma: a retrospective analysis of clinical efficacy and SLAMF7 expression patterns (2021) Danhof S, Rasche L, Mottok A, Steinmueller T, Zhou X, Schreder M, Kilian T, et al. Journal article Primary prophylaxis of bacterial infections and Pneumocystis jirovecii pneumonia in patients with hematologic malignancies and solid tumors: 2020 updated guidelines of the Infectious Diseases Working Party of the German Society of Hematology and Medical Oncology (AGIHO/DGHO) (2021) Classen AY, Henze L, Von Lilienfeld-Toal M, Maschmeyer G, Sandherr M, Graeff LD, Alakel N, et al. Journal article Abatacept as salvage therapy in chronic graft-versus-host disease—a retrospective analysis (2021) Wertheimer T, Dohse M, Afram G, Weber D, Heidenreich M, Holler B, Kattner AS, et al. Journal article COVID-19 infection in patients with multiple myeloma: a German-Chinese experience from Würzburg and Wuhan (2021) Zhou X, Bai T, Meckel K, Song J, Jin Y, Kortuem KM, Einsele H, et al. Journal article Cyclophosphamide for salvage therapy of chronic graft-versus-host disease: a retrospective analysis (2020) Fante MA, Holler B, Weber D, Angstwurm K, Bergler T, Holler E, Edinger M, et al. Journal article IL6-receptor antibody tocilizumab as salvage therapy in severe chronic graft-versus-host disease after allogeneic hematopoietic stem cell transplantation: a retrospective analysis (2020) Kattner AS, Holler E, Holler B, Klobuch S, Weber D, Martinovic D, Edinger M, et al. Journal article Donor-cell leukemia with novel genetic features 2 years after sex-mismatched T cell-depleted haploidentical stem cell transplantation (2020) Luber V, Lutz M, Thiede C, Haferlach C, Duerk HA, Einsele H, Grigoleit GU, Mielke S Journal article COVID-19 in cancer patients: clinical characteristics and outcome—an analysis of the LEOSS registry (2020) Rüthrich MM, Giessen-Jung C, Borgmann S, Classen AY, Dolff S, Grüner B, Hanses F, et al. Journal article Measuring the cellular memory B cell response after vaccination in patients after allogeneic stem cell transplantation (2020) Winkler J, Tittlbach H, Schneider A, Buchstaller C, Mayr A, Vasova I, Rösler W, et al. Journal article Long-term follow-up of rituximab in treatment of chronic graft-versus-host disease—single center experience (2019) Klobuch S, Weber D, Holler B, Edinger M, Herr W, Holler E, Wolff D Journal article